Search

everythinglearnresearchcommunity

for

Search:↓

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Hormonal therapies are safe and effective for treating adult women's acne.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.